Study of Norpsilocin Derivatives Reveals the Potential Importance of Monoalkyl Tryptamines
Norpsilocin is not psychoactive but minor changes to its chemical structure translate into major changes in its pharmacology.
External link. We are not responsible for the content.
Read more ↗More From Psychedelic Review
Women’s Health and Psychedelics – New Insights
Using validated behavior models and known standards, studies are finding significant differences between male and fem...
First Proof that Psilacetin is a Prodrug of Psilocin
Nichols and Frescas’ 1999 hypothesis becomes a validated scientific theory.
Magic Mushroom Industry Leaders: Top Cultivation Companies
Companies are deconstructing magic mushroom cocktails in search of therapeutic medicines.
Latest News
The Rush for Iboga Looks Different from Gabon
Gabonese civil servant and environmental lawyer Georges Gassita on what the ibogaine rush looks like from inside Gabo...
The Psychedelic Sector Has Grown Up. Wall Street Just Hasn’t Fully Realized It Yet
The sector experienced an early wave of enthusiasm fueled by bold promises, lofty valuations, and the belief that psy...
Do people hear voices when they take ayahuasca? 5 Questions with social anthropologist David Dupuis
Dupuis discusses how auditory hallucinations during psychedelic trips have been overlooked.
One of Psychedelia’s Most Notorious Gurus Is Officially Put on Blast
PLUS, stories about datura, the Huni Kuin, and Oregon's drug policy programs. [...] Read More... The post One of Psyc...
LSD Just Joined The Establishment
This Week’s Sunday Insider: The most anti-establishment Psychedelic in history is becoming part of the establishment.
Big changes ahead for Oregon’s psilocybin agency, New bill seeks to turn Trump’s psychedelics executive order into permanent law
Plus: Compass Pathways announces new Phase 3 results, and Lawsuit against LSD company Definium is dismissed